Search results for "minichiller"

Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing

The EFOX system delivers highly sensitive, full-scan data that helps labs detect persistent compounds faster, with more confidence, and in compliance with tightening regulations

How two CROs are uniting ligand-binding assays and LC-MS expertise to tackle the complexity of modern biologics

High-performance liquid chromatography (HPLC) stands as one of the foremost analytical techniques in use today. Its operational principle involves the separation of compounds according to their polarity. Unlike traditional liquid chromatography (LC), HPLC uses elevated pressure to propel the solvent through the column, significantly expediting separations while minimizing solvent usage.

Guest editorial features key takeaways from Balancing the Future Podcast, Season 1, Episode 3, by METTLER TOLEDO

Collaboration will evaluate the impact of the OMED solution on the digestive health and quality of life of participants in a workplace setting

Read Ocean Optics’ guest editorial exploring how these three key pillars are helping clinicians make faster, more informed treatment decisions at the bedside

Discover how advanced imaging technology is enabling continuous drug safety monitoring in liver organoids

In this guest editorial from Euroimmun, learn how immunoassay analyes support optimization of drug levels within the therapeutic window

Activace platform enables targeted, genome-wide profiling of unmethylated DNA regions, providing a comprehensive view of the epigenome that can be scaled to the study of large patient cohorts

Agreement will expand the availability of Gencurix’s in vitro diagnostic (IVD) assays using Droplet Digital™ PCR (ddPCR™) for clinical testing of critical oncology biomarkers across Europe

Up to 7,800 whole genomes and epigenomes to be sequenced on PacBio’s Revio system, powering one of the largest studies of healthy aging to date

Toni Ertl shares how The Native Antigen Company’s new human health recombinant proteins are advancing assay development in diagnostics and vaccine research